OnQuality Pharmaceuticals Ltd.
developing innovative drugs and drug delivery systems that improve the quality of life of oncology patients
developing innovative drugs and drug delivery systems that improve the quality of life of oncology patients
OnQuality Pharmaceuticals Ltd. is a healthcare startup based in China, founded in 2018. The company focuses on developing innovative drugs and drug delivery systems that improve the quality of life for oncology patients. With a slogan aiming to improve the lives of cancer patients, OnQuality has made significant strides in this direction.
OnQuality Pharmaceuticals Ltd. has built a substantial pipeline of products to address unmet clinical needs in the area of oncology supportive care. Currently, the company has one asset in Phase II, three in the pre-IND stage, and two others in the early development stage. These developments showcase the company's commitment to advancing cancer care.
The latest milestone in OnQuality's journey is a $20.00M Series A investment at 31 March 2021. The investment was led by a consortium of prominent investors including Matrix Partners China, Sinovation Ventures, BioTrack Capital, Shiyu Capital, Frees Fund, and CASH Capital. This not only underscores the potential and promise of OnQuality Pharmaceuticals but also highlights the confidence of these high-profile investors in the company's mission and approach.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | $20.00M | 6 |
|
31 Mar 2021 |
| Series A | $15.00M | 3 |
|
28 Oct 2019 |
No recent news or press coverage available for OnQuality Pharmaceuticals Ltd..
We care about your data, and we'd love to use cookies make your experience better.
